Emodin

DB07715InvestigationalSmall molecule

Emodin has been investigated for the treatment of Polycystic Kidney.

Mechanism: Pharmacologically active on Casein kinase II subunit alpha
Curator reviewed
Formula / weight: C₁₅H₁₀O₅ · 270.2369 g/mol (avg)
Also known as: Schuttgelb
Code names: NSC-408120 · NSC-622947

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyRHMXXJGYXNZAPX-UHFFFAOYSA-NSMILESCC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1

Targets

What you can answer from here — as of August 26, 2024

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

402Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Emodin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.